tirzepatide nejm ๐ข New in NEJM: ๐ vs. Semaglutide ๐ for obesity (no diabetes) ๐งช 72-week RCT highlights: โ๏ธ Weight loss: โ20.2% vs. โ13.7% ๐ Waist โ: 18.4 cm vs. 13.0 cm ๐ฏ More patients hit โฅ25% lossโฆ Head-to-Head: Tirzepatide Outperforms Semaglutide |
Pay in 4 interest-free payments of $5.45 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Aug 21 - Aug 26






/assets/production/practices/3280152d22c7599df4208c7f13bd6f106ba2a939/images/2788239.jpeg)


















